Healthy Skepticism Library item: 14872
Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.
Publication type: news
FDA Sends Abbott Letter About Humira
PharmaLive 2008 Dec 24
http://pharmalive.com/news/index.cfm?articleID=594701
Full text:
The FDA posted on its web site yesterday a letter it sent to Abbott Laboratories about a review of an American Academy of Dermatology (AAD) Post Meeting News Ad for Humira. According to the FDA, “This AAD Post Meeting News Ad broadens the approved indication and minimizes the risks associated with the use of HUMIRA. Therefore, this piece misbrands HUMIRA in violation of the Federal Food, Drug, and Cosmetic Act .”
